Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.
2.
3.

Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.

Yaylali V, Demirlenk I, Tatlipinar S, Ozbay D, Esme A, Yildirim C, Ozden S.

Acta Ophthalmol Scand. 2003 Aug;81(4):378-82.

4.
5.

Comparison of olopatadine and fluorometholone in contact lens-induced papillary conjunctivitis.

Khurana S, Sharma N, Agarwal T, Chawla B, Velpandian T, Tandon R, Titiyal JS.

Eye Contact Lens. 2010 Jul;36(4):210-4. doi: 10.1097/ICL.0b013e3181e4bb40.

PMID:
20531202
6.

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.

Lanier BQ, Finegold I, D'Arienzo P, Granet D, Epstein AB, Ledgerwood GL.

Curr Med Res Opin. 2004 Aug;20(8):1227-33.

PMID:
15324525
11.
12.

Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.

Mah FS, Rosenwasser LJ, Townsend WD, Greiner JV, Bensch G.

Curr Med Res Opin. 2007 Jun;23(6):1445-52. Epub 2007 May 18.

PMID:
17559743
13.

Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.

Figus M, Fogagnolo P, Lazzeri S, Capizzi F, Romagnoli M, Canovetti A, Iester M, Ferreras A, Rossetti L, Nardi M.

Eur J Ophthalmol. 2010 Sep-Oct;20(5):811-8.

PMID:
20383847
14.

Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.

Mortemousque B, Bourcier T, Khairallah M, Messaoud R, Brignole-Baudouin F, Renault D, Rebika H, Brémond-Gignac D; Ketotifen Study Group.

J Fr Ophtalmol. 2014 Jan;37(1):1-8. doi: 10.1016/j.jfo.2013.02.007. Epub 2013 Dec 31.

15.

A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.

Rosenwasser LJ, Mahr T, Abelson MB, Gomes PJ, Kennedy K.

Allergy Asthma Proc. 2008 Nov-Dec;29(6):644-53. doi: 10.2500/aap.2008.29.3176. Epub 2008 Dec 6.

PMID:
19063816
17.

A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.

Katelaris CH, Ciprandi G, Missotten L, Turner FD, Bertin D, Berdeaux G; International Olopatadine Study Group.

Clin Ther. 2002 Oct;24(10):1561-75.

PMID:
12462286

Supplemental Content

Support Center